文献速递慢性静脉疾病

功能不全Giacomini静脉的腔内激光消融结局

Outcomes of endovenous laser ablation in patients with incompetent Giacomini vein.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-08-29

这项前瞻性单中心研究纳入83条肢体(75例患者),评估EVLA治疗症状性Giacomini静脉功能不全的临床与超声结局。技术成功率100%,末次随访总体闭塞率96.4%,VCSS与QOL显著改善,无重大并发症,48个月免于再通率95.6%。

要点

  • EVLA治疗功能不全GV技术成功率达100%,末次随访闭塞率96.4%。
  • VCSS从基线6.9±1.4降至12个月2.1±1.4,QOL评分从50.4±4.8升至78.7±6.1。
  • 无深静脉血栓、肺栓塞或热诱导血栓形成等重大并发症。

核心结论

  • EVLA治疗功能不全GV具有高技术成功率、持久闭塞、临床症状改善和低并发症率。
  • 仍需进一步比较研究明确其相对其他腔内治疗方式的地位。

研究设计与样本

  • 前瞻性单中心队列研究,2018年1月至2024年1月连续纳入75例患者共83条肢体。
  • 诊断与反流评估采用双功能超声,临床严重程度按CEAP分类。

主要发现

  • 技术成功和术后即刻闭塞在所有治疗肢体中达100%。
  • 平均随访28.3±16.3个月,末次随访总体闭塞率96.4%(80/83条肢体)。
  • 部分再通2条(2.4%),完全再通1条(1.2%)。
  • VCSS从基线6.9±1.4降至12个月2.1±1.4,QOL评分从50.4±4.8升至78.7±6.1(均P<.001)。
  • Kaplan-Meier估计48个月免于再通率为95.6%。

关键数值与推荐

  • 主要结局为完全静脉闭塞,次要结局包括技术成功、症状改善、再通和并发症。
  • 随访在1、6、12个月及之后每年进行。

临床怎么用

  • 对于症状性GV功能不全,EVLA可作为有效腔内治疗选择。
  • 术后需超声随访监测再通,尽管再通率较低。

局限性

  • 单中心前瞻性队列设计,样本量有限。
  • 缺乏与其他腔内治疗方式的对照比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Giacomini vein (GV) incompetence is an uncommon cause of chronic venous disease, and evidence regarding its endovenous treatment remains limited. This study evaluated the clinical and duplex ultrasound outcomes of endovenous laser ablation (EVLA) in patients with incompetent GV. METHODS: This prospective single-center study included 83 limbs in 75 consecutive patients treated with EVLA for symptomatic GV incompetence between January 2018 and January 2024. Diagnosis and reflux assessments were performed using duplex ultrasound study. Clinical severity was classified according to the Clinical-Etiology-Anatomy-Pathophysiology classification, whereas clinical outcomes and quality of life (QOL) were assessed using the Venous Clinical Severity Score (VCSS) and the Venous Insufficiency Epidemiological and Economic Study-QOL questionnaire. The primary outcome was complete vein occlusion. Secondary outcomes included technical success, symptom improvement, recanalization, and complications. Follow-up was performed at 1, 6, and 12 months, and annually thereafter. RESULTS: Technical success and immediate postprocedural occlusion were achieved in all treated limbs (100%). The mean follow-up period was 28.3 ± 16.3 months. The overall occlusion rate at the latest follow-up was 96.4% (80/83 limbs). Partial and complete recanalization occurred in two (2.4%) and one (1.2%) limbs, respectively. Mean Venous Clinical Severity Score significantly improved from 6.9 ± 1.4 at baseline to 2.1 ± 1.4 at 12 months, whereas mean Venous Insufficiency Epidemiological and Economic Study-QOL score increased from 50.4 ± 4.8 to 78.7 ± 6.1 (both P < .001). No major complications, including deep vein thrombosis, pulmonary embolism, or endothermal heat-induced thrombosis, were observed. Kaplan-Meier estimated freedom from recanalization was 95.6% at 48 months. CONCLUSIONS: In this prospective single-center cohort, EVLA of the incompetent GV was associated with high technical success, durable occlusion, clinical improvement, and a low complication rate. Further comparative studies are needed to define its role relative to other endovenous treatment modalities.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Babić S, Milačić A, Slović B, et al. Outcomes of endovenous laser ablation in patients with incompetent Giacomini vein. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42668115. doi:10.1016/j.jvsv.2026.102607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。